(MENAFN- Straits Research)
Lice Treatment Market Size & Growth Analysis
The global lice treatment market size was valued at USD 1.13 billion in 2025 and is projected to grow from USD 1.20 billion in 2026 to USD 1.96 billion by 2034, registering a CAGR of 6.31% during the forecast period from 2026 to 2034. North America dominated the lice treatment market with a market share of 38.4% in 2025.
Lice feed exclusively on human blood and can be found on the scalp, behind the ears, and at the nape of the neck. Head lice can be transmitted quickly and easily from one person to another by close physical contact, and they are particularly common in children. Between the ages of 3 and 17, head lice affect the vast majority of school-aged children. An infection of the hair and scalp by Pediculus humanus capitis (the head louse) is known as pediculosis capitis. The sickness may have a reduced fatality rate, but it still causes stress for parents, carers, and teachers.
Lice Treatment Market Key Takeaways
Global Market Size & Growth
2025 Market Size: USD 1.13 Billion
2026 Market Size: USD 1.20 Billion
2034 Projected Market Size: USD 1.96 Billion
Forecast Period: 2026–2034
Base Year: 2025
Market CAGR (2026–2034): 6.31%
Regional Insights
Largest Regional Market (2025): North America
North America Market Share (2025): 38.4%
Fastest-Growing Region: Asia Pacific
Asia Pacific CAGR (2026–2034): 8.1%
Segment Insights
By Product Type
Leading Segment: OTC Medication
Market Share in 2025: 72.8%
By Distribution Channel
Fastest growing segment: Other Distribution Channels
CAGR: 7.6% (2026-2034)
Download a Free Sample To learn more about this report,
Lice Treatment Market Trends
Growing Shift Toward Pesticide-Free Lice Treatments
The lice treatment market is gradually shifting toward pesticide-free and physically acting products, especially for families looking for gentler treatment options for children. Traditional ingredients such as permethrin and pyrethrins are still widely used, but concerns about treatment resistance are influencing product development. As a result, companies are introducing formulations based on ingredients such as dimethicone, which works physically on lice rather than targeting their nervous system.
In August 2026, MAYDAY entered the active lice treatment category with its Lice Treatment Hair Solution. The pesticide-free product uses a dimethicone-based formulation that physically suffocates lice. Independent laboratory testing reported by the company showed 99% effectiveness against lice, super lice, and nits, including DNA-verified super lice strains.
This development highlights growing interest in non-pesticide treatments that are simple to use at home. With resistance reducing the effectiveness of some conventional treatments, manufacturers are focusing more on alternative mechanisms, family-friendly formulations, and products that address both live lice and nits.
Lice Treatment Market Dynamics
Market Drivers
Persistent Head Lice Infestations Among School-Age Children
The lice treatment market growth is supported by the continued occurrence of head lice, particularly among preschool and elementary-school children. Close physical contact in schools, childcare facilities, households, and other group environments makes transmission difficult to prevent completely. Lice treatment market demand is also supported by recurring infestations and increasing awareness among parents about early detection and appropriate treatment.
In March 2026, Cartwheel expanded the availability of its Nit Happens over-the-counter lice treatment across approximately 6,000 Walgreens locations in the U.S. The pesticide-free product targets lice and nits, demonstrating continued consumer interest in easily accessible treatment options.
Market Restraints
Treatment Failure and Resistance to Conventional Pediculicides
The lice treatment industry faces restraints from reduced effectiveness of some traditional insecticide-based products. Resistance to permethrin and pyrethrin can make infestations more difficult to eliminate, while incorrect application and reinfestation can further reduce treatment success. Some treatments also require a second application because they kill live lice without reliably eliminating unhatched eggs.
In November 2025, researchers evaluating commercially available pediculicide shampoos among schoolgirls in Thailand reported significant treatment failure. After two treatments, the permethrin shampoo group achieved a cure rate of only 6.67%, highlighting concerns surrounding resistance to conventional treatments.
Market Opportunities
Growing Availability of Pesticide-Free Treatment Alternatives
The lice treatment market size has opportunities to expand through non-insecticidal products that physically eliminate lice rather than relying on conventional neurotoxic insecticides. Dimethicone-based formulations are gaining attention because their physical mode of action can provide an alternative where resistance is a concern. Wider distribution through pharmacies, retail chains, and online channels can also help manufacturers strengthen lice treatment market share.
In August 2026, MAYDAY entered the active lice-treatment category with its pesticide-free, dimethicone-based Lice Treatment Hair Solution. The product was developed to address lice, nits, and resistant strains, expanding the availability of non-insecticidal treatment alternatives.
Market Challenges
Developing Treatments That Overcome Resistance and Improve Compliance
The lice treatment market trends are shifting toward convenient products capable of addressing resistant lice while reducing complicated treatment routines. Manufacturers must develop formulations that are safe for appropriate age groups, easy for consumers to apply, and effective against different stages of the lice life cycle. Treatment adherence remains another challenge because improper application or failure to repeat treatment when required can result in persistent infestations.
In August 2026, Pelthos Therapeutics highlighted preparations for the commercial launch of Xeglyze (abametapir), an FDA-approved head lice treatment, targeted for the third quarter of 2027. The company identified increasing resistance to established treatments such as pyrethrin, permethrin, and malathion as an important unmet need.
Lice Treatment Market Segmentation Analysis
By Product Type
OTC Medication Segment Dominated the Market with 72.8% Share
The OTC medication segment dominated the global lice treatment market with a 72.8% share, valued at USD 0.82 billion in 2025. OTC products are widely preferred because they provide convenient and easily accessible treatment options without requiring a prescription. Medicated shampoos, lotions, rinses, and other topical treatments are commonly purchased for managing head lice infestations, particularly among school-age children. Broad availability and ease of home treatment continue to support the segment's leading position.
The prescription medication segment is projected to register the fastest growth. Increasing treatment of persistent or difficult-to-manage lice infestations and the need for alternative therapies when conventional OTC products are ineffective are supporting prescription-based treatment demand.
Request Customization to receive a tailored report.
By Distribution Channel
Retail Pharmacies Segment Dominated the Market with 58.9% Share
The retail pharmacies segment dominated the global lice treatment market with a 58.9% share, valued at USD 0.67 billion in 2025. Retail pharmacies provide convenient access to shampoos, lotions, combs, and other lice management products, making them a major purchasing channel for households. Pharmacist guidance and widespread availability of OTC products further strengthen the segment's position.
Other distribution channels are projected to register the fastest growth. Increasing use of online pharmacies, e-commerce platforms, and direct-to-consumer channels is improving product accessibility and providing consumers with greater convenience and a wider selection of lice treatment products.
Speak to an Analyst to discuss market opportunities.
Lice Treatment Market Regional Outlook
North America Lice Treatment Market Analysis
North America's lice treatment market accounted for 38.4% of the global market, reaching USD 0.43 billion in 2025, and is projected to grow at a CAGR of 6.2% during the forecast period. The region's leading position is supported by high awareness of head lice management, easy access to over-the-counter treatments, established healthcare and pharmacy networks, and frequent screening among school-age children. Growing preference for convenient home-based treatments and increasing availability of pesticide-free and alternative lice removal products further support regional demand.
United States Lice Treatment Market Insights
The United States represents the major market in North America. High awareness among parents and schools, widespread availability of lice treatment products through pharmacies and retail channels, and demand for convenient home-use solutions continue to support market development. Increasing interest in non-toxic and pesticide-free treatment options is also influencing product adoption.
Canada Lice Treatment Market Insights
Canada's established pharmacy network, awareness of head lice prevention among families and schools, and easy availability of over-the-counter treatment products continue to support demand. Consumer preference for gentle formulations and alternative lice removal methods is also contributing to market development.
Unlock Regional Insights to access country-level data, & regional trends.
Asia Pacific Lice Treatment Market Analysis
The Asia Pacific lice treatment market accounted for 23.6% of the global market, reaching USD 0.27 billion in 2025, and is projected to grow at a CAGR of 8.1% during the forecast period. The region records the fastest growth among the listed markets, supported by its large child population, improving access to healthcare and pharmacies, rising awareness of personal hygiene, and increasing recognition of head lice infestation as a manageable health concern. Expanding retail and e-commerce channels are also improving access to treatment products.
China Lice Treatment Market Insights
China represents an important market within Asia Pacific. Its large population, expanding pharmacy and online retail networks, improving awareness of personal hygiene, and increasing availability of specialized lice treatment products continue to support demand.
Japan Lice Treatment Market Insights
Japan's strong emphasis on personal hygiene, developed healthcare system, and established pharmacy and personal care retail networks support demand for lice treatment products. Consumer preference for safe, easy-to-use, and gentle formulations also influences product selection.
Europe Lice Treatment Market Analysis
Europe's lice treatment market accounted for 27.1% of the global market, reaching USD 0.31 billion in 2025, and is expected to register a CAGR of 6.5% during the forecast period. The market is supported by widespread awareness of head lice among parents and schools, established pharmacy distribution, and regular use of over-the-counter treatments. Concerns surrounding resistance to conventional insecticide-based products are also encouraging demand for physical-action, silicone-based, and pesticide-free alternatives.
Germany Lice Treatment Market Insights
Germany represents a key European market, supported by strong consumer awareness, established pharmacy distribution, and continued demand for effective head lice management among school-age children. Growing preference for treatments that physically eliminate lice rather than relying solely on conventional insecticides is supporting product diversification.
United Kingdom Lice Treatment Market Insights
The United Kingdom has an established market for head lice treatments, supported by strong awareness among parents, schools, pharmacists, and healthcare professionals. Wide availability of treatments through pharmacies, supermarkets, and online channels continues to support consumer access and product adoption.
Latin America Lice Treatment Market Analysis
Latin America's lice treatment market accounted for 6.8% of the global market, reaching USD 0.08 billion in 2025, and is expected to grow at a CAGR of 7.0% during the forecast period. A significant school-age population, improving awareness of head lice management, expanding pharmacy networks, and greater availability of affordable treatment products are supporting regional development. Increasing access to healthcare information is also encouraging earlier identification and treatment of infestations.
Brazil Lice Treatment Market Insights
Brazil represents a major market in Latin America. Its large child population, expanding retail pharmacy network, increasing hygiene awareness, and demand for accessible home-based lice treatments continue to support the market. Greater availability of topical products and mechanical lice removal solutions is further widening consumer choice.
Middle East & Africa Lice Treatment Market Analysis
The Middle East & Africa lice treatment market accounted for 4.1% of the global market, reaching USD 0.05 billion in 2025, and is anticipated to grow at a CAGR of 6.7% during the forecast period. Improving access to pharmacies and healthcare services, increasing awareness of personal hygiene, and growing availability of over-the-counter treatment products are supporting regional demand. Public awareness and school health initiatives are also helping improve recognition and management of head lice infestations.
UAE Lice Treatment Market Insights
The UAE's developed healthcare infrastructure, extensive pharmacy network, high consumer awareness of personal hygiene, and availability of international healthcare and personal care brands continue to support demand for lice treatment products. Growing use of online pharmacies and e-commerce platforms is also improving consumer access to different treatment options.
Competitive Landscape
The global lice treatment industry is moderately fragmented, with pharmaceutical companies, consumer healthcar brands, and specialized lice-care providers competing across over-the-counter medications, prescription treatments, and pesticide-free solutions. Key players include Oystershell Consumer Health, Alliance Pharma Plc, Azurity Pharmaceuticals, Prestige Consumer Healthcare Inc., GSK plc, Johnson & Johnson Services Inc., and other regional manufacturers.
Industry participants are increasingly focusing on pesticide-free formulations, single-application therapies, naturally derived ingredients, improved retail availability, and treatments targeting resistant lice. Companies are also expanding pharmacy and mass-retail distribution to make head lice treatments more accessible to families while developing gentler alternatives to conventional insecticide-based products.
MAYDAY: An Emerging Market Player
MAYDAY is an emerging lice-care brand focused on pesticide-free prevention and active treatment products. The company is building a broader lice-management portfolio around formulations designed for families seeking alternatives to conventional pesticide-based treatments.
In August 2026, MAYDAY entered the active lice treatment category with the launch of its Lice Treatment Hair Solution. The dimethicone-based formulation physically targets lice rather than relying on conventional neurotoxic pesticides and is designed to address lice, resistant super lice, and nits.
List of Key and Emerging Players in Lice Treatment Market
Oystershell Consumer Health
Oystershell Consumer Health – Products
Alliance Pharma Plc
Azurity Pharmaceuticals
Prestige Consumer Healthcare Inc.
GlaxoSmithKline Plc
Johnson and Johnson Services Inc.
Key Industry Developments
June 2026: ParaPRO LLC expanded the commercialization of Natroba® (spinosad) Topical Suspension 0.9% through broader retail and pharmacy distribution, strengthening access to single-application prescription treatment for head lice infestations.
May 2026: Pelthos Therapeutics completed the acquisition of Xeglyze® (abametapir) Lotion, 0.74%, expanding its dermatology portfolio with an FDA-approved prescription treatment for head lice and preparing for a broader commercial launch.
October 2025: Alliance Pharma expanded the international distribution of Vamousse® head lice treatment products into additional European markets, strengthening its consumer healthcare portfolio.
September 2025: Hatchtech entered new commercialization partnerships to expand the global availability of Xeglyze® (abametapir) Lotion, increasing access to its single-application head lice treatment across key international markets.
Report Scope
Comments
No comment